Schedule 13D ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2019-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,359,679
Percent of class
40.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-039617
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Aug 13, 2019
Reporting period
Aug 08, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub